RE: Placing cannot be above 1p14 Apr 2025 08:21
The handling of the update was atrocious no idea what the thinking was or lack of including the reduction in the outlook from the services side in light of tariffs which no one still knows the outcome.
However Tutivia with medicare approval and the growth potential is now worth far more than the mcap on its own.
The ramp up in sales via the 19 US transplant centres should be significant.
'the Company expects continued growth in Tutiviaâ„¢ with the ability of Verici to scale testing of Tutiviaâ„¢ through its own direct to physician sales. With the positive coverage determination now received, the Company is now able to recognise revenues.'
The elephant in the room is the funding.But with Tutivia now approved,revenues now recognised and sales growing fast the amount needed may be lower than thought. A revisit on the services side may be a good idea.
Only time will tell.
GL.